Should I take one pill of trotagliptin a week?
Trelagliptin (Trelagliptin) is an oral hypoglycemic drug taken once a week. This drug is a dipeptidyl peptidase-4 (DPP-4) inhibitor. By inhibiting the activity of the DPP-4 enzyme, it increases the level of glucagon-like peptide-1 (GLP-1) in the body, thereby improving blood sugar control. Trelagliptin is unique in that it has a long-acting effect, allowing patients to maintain stable blood sugar control by taking it only once a week.
Trelagliptin is usually available in a dosage of 100 mg per tablet. For most people with type 2 diabetes, the recommended dose is 100 mg once a week. This way of taking medication not only simplifies the treatment plan, but also improves patients' medication compliance. However, for patients with moderate renal impairment, it is recommended that the dose be halved to 50 mg once weekly.

The once-weekly administration of trotagliptin brings many conveniences to patients. First, it reduces the tedious task of taking medication every day for patients and reduces the likelihood of forgetting to take a medication or missing a medication schedule. Secondly, this way of taking medication helps reduce patients’ psychological burden and improve their quality of life. Finally, the long-acting effect of trolagliptin keeps blood sugar levels stable for a longer period of time, reducing the impact of blood sugar fluctuations on patients' health.
However, despite the many advantages of troagliptin, there are still some things to be aware of during use. First of all, patients should use trotagliptin under the guidance of a doctor to ensure that the dosage and usage of the drug are correct. Secondly, patients should pay close attention to blood sugar changes during use and regularly monitor blood sugar levels so that the drug dosage can be adjusted in a timely manner. In addition, patients should also pay attention to observe whether there are drug side effects or adverse reactions, such as hypoglycemia, gastrointestinal discomfort, etc. If there are any abnormalities, they should seek medical treatment in time.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)